LGALS9 and HIV infectious disease: However, although the loss of Tim-3+ NK cells over time is more pronounced in HIV-infected patients with low CD4+ T cell counts, there is no difference in plasma galectin-9 levels between HAART (highly active antiretroviral therapy)-treated and untreated subjects with progressive or controlled HIV infection [20].